Department of Pharmacology, Maulana Azad Medical College & Associated Hospitals, New Delhi, India.
Department of Pediatrics, Lok Nayak Hospital, New Delhi, India.
Indian J Pediatr. 2021 Mar;88(3):227-234. doi: 10.1007/s12098-020-03220-3. Epub 2020 Feb 21.
To assess the availability of pediatric formulations in Essential Medicines Lists and public health care facility in India.
Availability of pediatric formulations in the public health sector was evaluated by assessing inclusion of pediatric formulations in the National List of Essential Medicines (NLEM), Delhi Essential Medicine List (DEML), Indian Academy of Pediatrics (IAP) Essential Medicines Lists (EML) and comparing it with the World Health Organization's list of essential medicines for children (WHO, EMLc). In addition, availability of 30 essential medicines in a public, tertiary care hospital was assessed over a period of 1 y.
Many medicines present in WHO EMLc were not there in NLEM and DEML. The number of pediatric medicines formulations not available in pediatric doses as compared to WHO EMLc was 98,97 and 97 in NLEM, DEML and IAP respectively. Palliative care was the most neglected area in all the lists. In the public health care facility, only 53% of the tracer pediatric medicines were available.
There is less availability of pediatric formulations in the Indian NEML and state DEML. Availability of key tracer pediatric medicine formulations in public health facility is poor. A separate pediatric EML is required in the country to improve focus on availability of child-specific formulations.
评估印度基本药物清单和公共卫生保健机构中儿科制剂的可获得性。
通过评估国家基本药物清单（NLEM）、德里基本药物清单（DEML）、印度儿科学会（IAP）基本药物清单（EML）中是否包含儿科制剂，以及将其与世界卫生组织儿童基本药物清单（WHO，EMLc）进行比较，评估公共卫生部门儿科制剂的可获得性。此外，还评估了一家公立三级保健医院在 1 年内 30 种基本药物的可获得性。
许多存在于 WHO EMLc 中的药物并未出现在 NLEM 和 DEML 中。与 WHO EMLc 相比，NLEM、DEML 和 IAP 中没有儿科剂量的儿科药物制剂数量分别为 98、97 和 97。姑息治疗是所有清单中最被忽视的领域。在公共卫生保健机构中，只有 53%的追踪儿科药物可用。
印度国家基本药物清单和邦基本药物清单中儿科制剂的可获得性较低。公共卫生机构中关键追踪儿科药物制剂的可获得性较差。该国需要制定单独的儿科 EML，以提高对儿童专用制剂可获得性的关注。
